Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing.

Wu J, Wang SH, Potter D, Liu JC, Smith LT, Wu YZ, Huang TH, Plass C.

BMC Genomics. 2007 May 24;8:131.

2.

Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia.

Taylor KH, Pena-Hernandez KE, Davis JW, Arthur GL, Duff DJ, Shi H, Rahmatpanah FB, Sjahputera O, Caldwell CW.

Cancer Res. 2007 Mar 15;67(6):2617-25.

4.

DNA methylation immediately adjacent to active histone marking does not silence transcription.

Brinkman AB, Pennings SW, Braliou GG, Rietveld LE, Stunnenberg HG.

Nucleic Acids Res. 2007;35(3):801-11. Epub 2007 Jan 3.

5.

Comparative isoschizomer profiling of cytosine methylation: the HELP assay.

Khulan B, Thompson RF, Ye K, Fazzari MJ, Suzuki M, Stasiek E, Figueroa ME, Glass JL, Chen Q, Montagna C, Hatchwell E, Selzer RR, Richmond TA, Green RD, Melnick A, Greally JM.

Genome Res. 2006 Aug;16(8):1046-55. Epub 2006 Jun 29.

6.

Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.

Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, Andreesen R, Rehli M.

Cancer Res. 2006 Jun 15;66(12):6118-28.

7.

Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state.

McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T, Baylin SB.

Cancer Res. 2006 Apr 1;66(7):3541-9.

8.

Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?

Baylin SB, Ohm JE.

Nat Rev Cancer. 2006 Feb;6(2):107-16. Review.

PMID:
16491070
9.

Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry.

Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, van den Boom D.

Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15785-90. Epub 2005 Oct 21.

10.

Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.

Selzer RR, Richmond TA, Pofahl NJ, Green RD, Eis PS, Nair P, Brothman AR, Stallings RL.

Genes Chromosomes Cancer. 2005 Nov;44(3):305-19.

PMID:
16075461
11.

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.

Brell M, Tortosa A, Verger E, Gil JM, Viñolas N, Villá S, Acebes JJ, Caral L, Pujol T, Ferrer I, Ribalta T, Graus F.

Clin Cancer Res. 2005 Jul 15;11(14):5167-74.

12.
13.

MADE4: an R package for multivariate analysis of gene expression data.

Culhane AC, Thioulouse J, Perrière G, Higgins DG.

Bioinformatics. 2005 Jun 1;21(11):2789-90. Epub 2005 Mar 29.

PMID:
15797915
14.

Genomic maps and comparative analysis of histone modifications in human and mouse.

Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, McMahon S, Karlsson EK, Kulbokas EJ 3rd, Gingeras TR, Schreiber SL, Lander ES.

Cell. 2005 Jan 28;120(2):169-81.

15.

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas.

Paz MF, Yaya-Tur R, Rojas-Marcos I, Reynes G, Pollan M, Aguirre-Cruz L, García-Lopez JL, Piquer J, Safont MJ, Balaña C, Sanchez-Cespedes M, García-Villanueva M, Arribas L, Esteller M.

Clin Cancer Res. 2004 Aug 1;10(15):4933-8.

16.

Mapping global histone acetylation patterns to gene expression.

Kurdistani SK, Tavazoie S, Grunstein M.

Cell. 2004 Jun 11;117(6):721-33.

17.

Prognostically useful gene-expression profiles in acute myeloid leukemia.

Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, Beverloo HB, Moorhouse MJ, van der Spek PJ, Löwenberg B, Delwel R.

N Engl J Med. 2004 Apr 15;350(16):1617-28.

18.

High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays.

Oberley MJ, Tsao J, Yau P, Farnham PJ.

Methods Enzymol. 2004;376:315-34. Review. No abstract available.

PMID:
14975315
19.

Gene silencing in cancer in association with promoter hypermethylation.

Herman JG, Baylin SB.

N Engl J Med. 2003 Nov 20;349(21):2042-54. Review. No abstract available.

PMID:
14627790
20.

Aberrant methylation and impaired expression of the p15(INK4b) cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML).

Tessema M, Länger F, Dingemann J, Ganser A, Kreipe H, Lehmann U.

Leukemia. 2003 May;17(5):910-8.

PMID:
12750705

Supplemental Content

Support Center